Trial Profile
Phase Ib trial of oral CR 845 in healthy male volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Sep 2012
Price :
$35
*
At a glance
- Drugs Difelikefalin (Primary)
- Indications Pain
- Focus Adverse reactions; Biomarker; Pharmacodynamics; Pharmacokinetics
- 31 Aug 2012 Results presented at the 14th World Congress on Pain.
- 03 Apr 2012 Status changed from recruiting to completed, according to a Cara Therapeutics media release.
- 22 Nov 2011 Status changed from planning to recruiting, according to a Cara Therapeutics media release